Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group - Wikidata - wikimedia - TriplyDB

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

http://www.wikidata.org/entity/Q35013983

about

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

http://www.wikidata.org/entity/Q35013983

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

@ast

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

@en

type

label

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

@ast

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

@en

prefLabel

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

@ast

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

@en

P1433

Q35013983-DCCFAC92-3B26-4449-8BF0-91595B6FB2AA

P1476

Q35013983-D955CEA8-F216-4F81-81A3-EBA92625C9B8

P2093

Q35013983-0A100928-EE0C-4412-8DA9-2FF8114A88FC

Q35013983-110B5645-0EE8-49AD-9DD9-B634AA3A58DC

Q35013983-277EA4C1-7769-458E-85E5-CC4C17593DF0

Q35013983-43536C56-8939-4CE1-A795-5FE7DF3EEBC5

Q35013983-4C21F24B-8DF0-4D5C-A410-25A5CDC51B90

Q35013983-5F1BAA94-0913-46F2-BF29-D5FB60B233C9

Q35013983-75421882-EBD1-4F2C-9C82-E2841D4EDB66

Q35013983-79E421CA-8686-495A-8D4F-E5D0946B66A2

Q35013983-BA53E257-F117-4A06-B87A-D7FCD173D606

Q35013983-C35DE665-13E4-4FB7-AFCE-FEE5795D05BB

P2860

Q35013983-181EC707-5E30-47F9-97FE-D2D55AA61AF1

Q35013983-2A03D187-FF77-4F6B-A135-E47FEC6BD62A

Q35013983-2F40B60D-BECA-4A6F-9A64-3038AB5C1B1A

Q35013983-347D7BE5-A1E8-4E6A-B79B-08FA3E35CEDE

Q35013983-6C88976F-A7C6-478F-AB70-21E496AB11C5

Q35013983-75760887-60BE-49BA-B3CC-E92BB9D6110B

Q35013983-8A41816C-9CFB-42A1-824C-5CF8A6CB2C65

Q35013983-958424B9-B77D-4357-B04F-2AB97A4F93E7

Q35013983-98129908-125D-4193-B5C3-0DAF50578B24

Q35013983-A49CC6D9-67FC-4C93-8362-9DBEAC150F9F

P304

Q35013983-5E9CA1E1-9541-453F-A5B5-A7773B57D310

P31

Q35013983-0FDD3A48-C583-425D-8CFF-35ADC2363B62

P433

Q35013983-481D17B4-EC40-40B9-A900-EA994C5BB8D9

P478

Q35013983-8FF280B0-1845-476B-8359-5C56E42CEFBB

P577

Q35013983-5BDE9A3E-1571-424C-A0BB-AB6B95D1306B

P698

Q35013983-2CEEE39F-314F-400B-A7AA-1FEDF2A6EB96

P921

Q35013983-88939322-15D7-4797-9699-3AD53412F21C

P932

Q35013983-91275FF0-F92D-46D3-B7BF-48A0F81EA0A1

P1433

Gastroenterology & hepatology

P1476

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

@en

P2093

Adam S Cheifetz

http://www.w3.org/2001/XMLSchema#string

Brian Bressler

http://www.w3.org/2001/XMLSchema#string

Corey A Siegel

http://www.w3.org/2001/XMLSchema#string

Fernando S Velayos

http://www.w3.org/2001/XMLSchema#string

Gil Y Melmed

http://www.w3.org/2001/XMLSchema#string

Jennifer Jones

http://www.w3.org/2001/XMLSchema#string

Laura E Harrell

http://www.w3.org/2001/XMLSchema#string

Leonard Baidoo

http://www.w3.org/2001/XMLSchema#string

Miles P Sparrow

http://www.w3.org/2001/XMLSchema#string

Patricia L Kozuch

http://www.w3.org/2001/XMLSchema#string

P2860

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.

National Cooperative Crohn's Disease Study: results of drug treatment.

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.

P304

713-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21960891

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

3104182

http://www.w3.org/2001/XMLSchema#string